TAU AND AMYLOID PROTEIN LOWERING COMPOUNDS AND METHODS OF USE

Nasser Hussein Zawia

TAU AND AMYLOID PROTEIN LOWERING COMPOUNDS AND METHODS OF USE

Nasser Hussein Zawia (Inventor)

Qatar Biomedical Research Institute

Qatar Foundation for Education, Science, and Community Development

Research output: Patent

Abstract

Methods and compositions for treating neurodegenerative diseases in a patient in need thereof are provided. The methods include administering to the patient a therapeutically effective amount of a Tolfenamic Acid (TA) analog or a pharmaceutically acceptable salt thereof. The TA analog may be 2-(2-cyanophenylthio) benzoic acid or a pharmaceutically acceptable salt thereof.

Original language	English
Patent number	US2023381133
IPC	A61P 25/ 28 A I
Priority date	26/05/23
Publication status	Published - 30 Nov 2023

Cite this

@misc{c0fd018006a84140b09c3eb2d689727d,

title = "TAU AND AMYLOID PROTEIN LOWERING COMPOUNDS AND METHODS OF USE",

abstract = "Methods and compositions for treating neurodegenerative diseases in a patient in need thereof are provided. The methods include administering to the patient a therapeutically effective amount of a Tolfenamic Acid (TA) analog or a pharmaceutically acceptable salt thereof. The TA analog may be 2-(2-cyanophenylthio) benzoic acid or a pharmaceutically acceptable salt thereof.",

author = "Zawia, \{Nasser Hussein\}",

year = "2023",

month = nov,

day = "30",

language = "English",

type = "Patent",

note = "US2023381133; A61P 25/ 28 A I",

}

TY - PAT

T1 - TAU AND AMYLOID PROTEIN LOWERING COMPOUNDS AND METHODS OF USE

AU - Zawia, Nasser Hussein

PY - 2023/11/30

Y1 - 2023/11/30

N2 - Methods and compositions for treating neurodegenerative diseases in a patient in need thereof are provided. The methods include administering to the patient a therapeutically effective amount of a Tolfenamic Acid (TA) analog or a pharmaceutically acceptable salt thereof. The TA analog may be 2-(2-cyanophenylthio) benzoic acid or a pharmaceutically acceptable salt thereof.

AB - Methods and compositions for treating neurodegenerative diseases in a patient in need thereof are provided. The methods include administering to the patient a therapeutically effective amount of a Tolfenamic Acid (TA) analog or a pharmaceutically acceptable salt thereof. The TA analog may be 2-(2-cyanophenylthio) benzoic acid or a pharmaceutically acceptable salt thereof.

M3 - Patent

M1 - US2023381133

ER -

TAU AND AMYLOID PROTEIN LOWERING COMPOUNDS AND METHODS OF USE

Abstract

Fingerprint

Cite this